Longyi blood glucose test system
Taiwan·Risk Class 2·Taibo Technology Co., Ltd. five-stock factory·Registered Jan 17, 2006 – Jan 17, 2011Cancelled- Analysis ID
- d3ab31442de986d6077f83dc895ba08f
- Customs Code
- DHY00500197400
- Manufacturer
- Taibo Technology Co., Ltd. five-stock factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- DRAGON PHARMACEUTICAL CO., LTD.
- Intended Use
- Longyi blood glucose test system provides quantitative blood glucose testing, which is suitable for self-measurement of blood sugar by diabetic patients or blood glucose testing by medical professionals. This system is suitable for fresh microvascular blood for blood glucose detection.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Domestic
- Registration Date
- Jan 17, 2006
- Expiry Date
- Jan 17, 2011
- Cancellation Date
- Nov 09, 2012
- Status
- Logged out
- Reason
- 許可證已逾有效期
Top companies providing products similar to "Longyi blood glucose test system"
Recently registered similar products
Access comprehensive regulatory information for Longyi blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d3ab31442de986d6077f83dc895ba08f and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is DRAGON PHARMACEUTICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory, Taibo Technology Co., Ltd. five-stock factory, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.